Trial intelligence / Profile preview

Intramuscular calcitonin for pain and function in knee osteoarthritis

IRCT20130518013364N9Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jul 2020
Modality
Small Molecules, Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of TBRIA in knee osteoarthritis (OA) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: pain. Started Jul 2020; status: completed.

02

Drugs

TBRIA
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on IRCT20130518013364N9.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130518013364N9.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call